This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Chinese innovators need adaptable patent strategies amid US clampdown on tech in connected vehicles

By MLex Staff ( September 30, 2024, 02:31 GMT | Comment) -- In a shifting landscape of global technological competition, the US government’s strategic goal to sever ties with China in pivotal sectors like automotives, semiconductors and information technology is sending ripples through the realm of patents. As restrictions loom over Chinese connected vehicles entering the US market, patent holders face a critical juncture in sculpting their long-term strategies. The evolving dynamics could potentially reshape how innovative technologies are protected, commercialized and monetized on a global scale.In a shifting landscape of global technological competition, the US government’s strategic goal to sever ties with China in pivotal sectors like automotives, semiconductors and information technology is sending ripples through the realm of patents....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections